Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.


In today’s clinical research environment, the pressure to deliver faster, higher-quality results is greater than ever. Clinical leaders, data management professionals and biostatistics teams face persistent challenges with slow database builds, which can delay study start-up, hinder patient recruitment and ultimately impact time-to-market for new therapies. Register for this webinar to learn how AI, automation and standardized workflows can accelerate study start-up while improving efficiency and data quality across teams.
Traditional database setup processes are often manual, fragmented and prone to rework, creating inefficiencies that ripple across data management and statistical programming workflows. These delays not only increase operational risk but also compress timelines for downstream activities such as study data tabulation model (SDTM) conversion and analysis readiness. As the demand for real-time data insights and rapid study deployment grows, the industry needs innovative solutions that streamline workflows, harmonize standards and enable teams to move from protocol to first-patient-in with unprecedented speed and confidence. In this webinar, attendees will learn how digitized protocols, AI-driven standards comparison and automated electronic case report form (eCRF)/edit check generation — now delivered through IQVIA’s enhanced Medidata EDC offerings — let teams choose the right build path: Fast-Build (~4 weeks) for standards-led studies, Standard (~8 weeks) when moderate tailoring is needed and Custom (~12 weeks) for higher complexity — each governed by IQVIA standards libraries and compliance reporting.
The featured speakers will highlight how biostatistics, automation and cross-therapeutic standards come together in Medidata to boost productivity, consistency and quality across the data lifecycle, with real-world cases showing measurable gains in compliance and operational efficiency. All of this is led by IQVIA’s Data Sciences, Safety and Medical (DSSM) team via Push Button Start-up (PBSU) and EDC Recommender, working hand-in-hand with Medidata EDC to transform database build — from protocol to first-patient-in — with speed and confidence.
Key points will include the strategic value of cross-functional collaboration, the importance of harmonizing standards from protocol design through to analysis and the practical steps organizations can take to avoid working in silos. The DSSM team will also address readiness for client-facing deployment, dependencies on standards metadata and the critical role of presenter expertise in driving successful adoption. Whether you oversee statistical programming, data management or clinical operations, this session will equip you with actionable insights and proven strategies to accelerate your path to database lock and clinical study report (CSR) delivery.
Join this webinar to gain a competitive edge in clinical trial delivery. Discover how leading organizations are leveraging PBSU and DSSM technologies to overcome bottlenecks, reduce cycle times and ensure submission-ready outputs. Attendees will leave with a clear understanding of how to operationalize governed standards, automate key processes and drive measurable impact across study start-up.
For more information and to register, click here.
Sean Brandyberry, VP, Global Clinical Data Management, IQVIA
Paul Slagle, Senior Director, Statistical Programming, IQVIA
Nina Reyes, Director, Clinical Data Management, IQVIA
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.